KRT14 and neoplasm: In concordance with in vivo murine studies, demonstrating that dysregulated expression of the α2β1 integrin did not alter malignant conversion in SCC, α2β1 integrin expression in the K14-HPV16 model did not affect later aspects of tumor progression [48].